EcoDrugPlus

Ribosomal Protein S25

Ensembl ID : ENSCVAG00000010101
Gene Symbol: RPS25
3 Cross references
472 Possible Orthologues:

Ribosomal Protein S26

Ensembl ID : ENSCVAG00000001274
Gene Symbol: RPS26
3 Cross references
416 Possible Orthologues:

Ribosomal Protein S28

Ensembl ID : ENSCVAG00000012656
Gene Symbol: RPS28
3 Cross references
274 Possible Orthologues:

Ribosomal Protein S3a

Ensembl ID : ENSCVAG00000019113
Gene Symbol: RPS3A
4 Cross references
372 Possible Orthologues:

Ribosomal Protein S4 X-Linked

Ensembl ID : ENSCVAG00000013044
Gene Symbol: RPS4X
3 Cross references
497 Possible Orthologues:

Ribosomal Protein S7

Ensembl ID : ENSCVAG00000018688
Gene Symbol: RPS7
3 Cross references
370 Possible Orthologues:

Ribosomal Protein S8

Ensembl ID : ENSCVAG00000017967
Gene Symbol: RPS8
3 Cross references
327 Possible Orthologues:

Ribosomal Protein S9

Ensembl ID : ENSCVAG00000007999
Gene Symbol: RPS9
3 Cross references
237 Possible Orthologues:

Ribosomal Protein Sa

Ensembl ID : ENSCVAG00000007308
Gene Symbol: RPSA
4 Cross references
516 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSCVAG00000002662
Gene Symbol: RPLP0
3 Cross references
403 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P1

Ensembl ID : ENSCVAG00000002940
Gene Symbol: RPLP1
3 Cross references
386 Possible Orthologues:

Serine/threonine-Protein Kinase A-Raf-Like

Ensembl ID : ENSCVAG00000002809
Gene Symbol: LOC107104990
3 Cross references
191 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).